Eclipse Bioinnovations has introduced the eMERGE platform, which has been designed to improve the development of RNA-based medicines. The end-to-end platform facilitates the study of therapeutic translation, stability-influencing structure, mRNA substance identity and integrity, and lipid nanoparticle and storage effects. In addition to providing comprehensive characterizations, the platform can perform analyses that can be used to optimize processes such as the identification of sequences for translation and stability.
Eclipse Bioinnovations
www.eclipsebio.com
